PHARMALA BIOTECH HOLDINGS INC. financial statements, including revenue, expenses, and profit

The total revenue of MDMA for the last quarter is 57.30 k CAD, and it's 9.01% higher compared to the previous quarter. The net income of Q1 25 is -479.11 k CAD.